RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
8.24
-0.24 (-2.83%)
Oct 17, 2025, 4:00 PM EDT - Market closed
RxSight Market Cap
RxSight has a market cap or net worth of $337.15 million as of October 20, 2025. Its market cap has decreased by -82.14% in one year.
Market Cap
337.15M
Enterprise Value
121.37M
1-Year Change
-82.14%
Ranking
Category
Stock Price
$8.24
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $337.15M, a decrease of -20.55%. That is a compound annual growth rate of -5.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 337.15M | -75.67% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | 424.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.59B |
| Johnson & Johnson | 462.69B |
| AbbVie | 400.78B |
| UnitedHealth Group | 323.03B |
| AstraZeneca | 261.44B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 222.13B |